Respiratory failure due to Pneumocystis carinii following methotrexate therapy for gestational trophoblastic disease.
Barbier
Christophe
C
Department of Intensive Care Unit, CHI Poissy/Saint-Germain-en-Laye, 78105 Saint-Germain-en-Laye, France.
Arnaout
Leïla
L
Schmit
Christophe
C
Aucouturier
Jean-Sébastien
JS
Ricome
Jean-Louis
JL
Loubières
Yann
Y
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000378:metabolism; D005260:Female; D006801:Humans; D002820:Hydatidiform Mole, Invasive / Q000097:blood / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008727:Methotrexate / Q000009:adverse effects*; D009894:Opportunistic Infections / Q000150:complications* / Q000188:drug therapy; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000150:complications* / Q000188:drug therapy; D011247:Pregnancy; D012131:Respiratory Insufficiency / Q000382:microbiology*; D019233:Retreatment; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000097:blood / Q000188:drug therapy; D014620:Vacuum Extraction, Obstetrical / Q000379:methods
D000890:Anti-Infective Agents; D018997:Chorionic Gonadotropin, beta Subunit, Human; D007166:Immunosuppressive Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D008727:Methotrexate